Related Experiment Videos
Bacterial probiotic modulation of dendritic cells.
Maureen Drakes1, Thomas Blanchard, Steven Czinn
1Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA. mld19@cwru.edu
Infection and Immunity
|May 25, 2004
Summary
Bacterial probiotics, like VSL#3, can alter dendritic cell function. This modulation of immune cells and cytokine release may explain their benefits in treating intestinal diseases.
Area of Science:
- Immunology
- Gastroenterology
- Microbiology
Background:
- Intestinal dendritic cells (DCs) are crucial immune sentinels constantly exposed to gut microbes.
- DCs activate T-cells and release chemokines, influencing local immune responses.
- Bacterial probiotics are increasingly used for intestinal disorders like inflammatory bowel disease (IBD).
Purpose of the Study:
- To investigate how the probiotic VSL#3 affects dendritic cell surface antigen expression and cytokine production.
- To understand the immunomodulatory mechanisms of probiotics in the gut.
Main Methods:
- Bone marrow-derived dendritic cells were stimulated with the probiotic VSL#3.
- Cell surface antigen expression was analyzed using monoclonal antibody staining.
- Cytokine levels were quantified using enzyme-linked immunosorbent assay (ELISA).
Main Results:
- High-dose VSL#3 upregulated key dendritic cell surface molecules (CD80, CD86, CD40, MHC class II).
- VSL#3 significantly enhanced the release of interleukin-10 (IL-10).
- Probiotic treatment did not enhance T-cell proliferation induction, unlike E. coli stimulation.
Conclusions:
- Probiotics modulate dendritic cell phenotype and cytokine profiles.
- The enhanced IL-10 production by DCs may contribute to the therapeutic effects of probiotics in intestinal diseases.
- Probiotics offer a potential strategy for immune regulation in the gut.